Summary

Overview
Global Dual-energy X-ray Absorptiometry (DEXA) Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX % during the forecast period 2023-2030.
Dual-energy X-ray absorptiometry (DEXA or DXA) is a medical imaging technology that is primarily used to measure bone mineral density (BMD) and body composition. It can differentiate between bone, fat, and lean tissue using two distinct energy levels of X-ray radiation. In order to identify osteoporosis, a disorder marked by weakening bones and an elevated risk of fractures, DEXA scans are frequently carried out.
DEXA scans are frequently used to evaluate fracture risk and diagnose osteoporosis. It calculates the bone mineral density (BMD) in the wrist, hip, and spine, among other body parts. Osteoporosis or osteopenia (low bone mass) are conditions that increase the risk of fractures and are indicated by poor bone density. DEXA scans are used to track how changes in lifestyle and osteoporosis medicines affect bone health.
Market Dynamics: Drivers and Restraints
Increasing the prevalence of osteoporosis
Osteoporosis is a common bone disease, especially among the aging population and postmenopausal women. The need for early diagnosis and monitoring of osteoporosis fuels the demand for DEXA systems. For instance, according to Bone Health Osteoporosis Foundation, stated that, osteoporosis is a disease of the bone that makes a person’s bones weak and more likely to break.
Approximately 10 million Americans have osteoporosis and another 44 million have low bone density, placing them at increased risk. Around 54 million Americans, half of all adults age 50 and older, are at risk of breaking a bone and should be concerned about bone health. Moreover, according to IOF, stated that, in Germany approximately 831,000 new fragility fractures occurred in 2019, estimated to increase by 16.4% in 2034 (967,000 fractures in 2034). Thus the prevalence of diseases accelerates the market growth.
The market is growing as a result of ongoing technological developments in DEXA systems that improve accuracy, speed, and safety and draw in both patients and healthcare professionals. Healthcare facilities may now afford to invest in cutting-edge diagnostic tools like DEXA systems because to increases in healthcare spending in developed as well as developing nations.
Market Dynamics: Restraint
Dual-energy X-ray Absorptiometry (DEXA) systems are in high demand due to a number of causes, however the market may also be constrained by a few factors. DEXA equipment, for example, are costly to buy and operate. Their adoption may be hampered by the initial outlay and ongoing maintenance expenses, which can be particularly high for small clinics and healthcare facilities.
Furthermore, non-ionizing radiation alternatives for bone density testing are provided by alternative diagnostic technologies such peripheral quantitative computed tomography (pQCT) and quantitative ultrasonography (QUS). The market demand for DEXA systems may be impacted by these companies.
For more details of the report, Request for sample
Segment Analysis
The global dual-energy x-ray absorptiometry market is segmented based on type, application, end-user and region.
The central DEXA segment from the type segment accounted for approximately 41.7% of dual-energy x-ray absorptiometry market
The medical industry uses Central Dual-Energy X-ray Absorptiometry, or Central DEXA, for a number of applications. For instance, central DEXA is the gold standard for diagnosing osteoporosis and determining fracture risk because it measures bone mineral density (BMD) with extreme precision and accuracy. Its precision is essential for deliberating about patient treatment in a trained approach.
Furthermore, because central DEXA is a non-invasive imaging method, no surgery or instrument insertion is necessary. Because it is non-invasive, it is the method of choice for assessing bone health, particularly in patients who are elderly or weak. Additionally, the efficacy of lifestyle modifications and osteoporosis therapy is tracked by central DEXA. Frequent scans give medical personnel the ability to monitor changes in bone density over time and make any required modifications to treatment programmes. As a result, the segment's features aid the market grow.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is expected to dominate the overall DEXA market throughout the forecast period. The market growth is due to the presence of key players, the high prevalence of osteoporosis patients in the region, established healthcare infrastructure, and the availability of DEXA devices in most of the hospitals.
For instance, the healthcare system in the United States was highly developed, with a large number of hospitals, clinics, and medical institutions. The accessibility and availability of DEXA machines across the nation are supported by this infrastructure. In the United States, the importance of preventative healthcare is increasing.
Although DEXA scans make it possible to detect osteoporosis early and take appropriate action to prevent fractures, they are essential in the field of preventive medicine. In addition, a large portion of the American population is older, and this increases their risk of osteoporosis. Consequently, there is an increased need for bone density evaluations, which results in the regular usage of DEXA scans. Therefore, the expansion of the region is accelerated by the above factors.
COVID-19 Impact Analysis
In order to prioritise resources for COVID-19 patients, several non-essential medical procedures, such as DEXA scans, were cancelled or postponed during the peak of the pandemic. As a result, fewer DEXA scans were conducted, which had an impact on the earnings of the companies who made the DEXA systems and the medical facilities that provided these services.
Global supply chains were thrown off balance by the epidemic, which led to delays in the production and delivery of medical equipment, including DEXA devices. This made it more difficult for medical establishments to replace their old DEXA devices with new ones. Similar to other healthcare industry sectors, the DEXA market began to gradually recover as immunization efforts and healthcare systems adjusted to the obstacles presented by the pandemic.
Market Segmentation
By Type
• Peripheral DEXA
• Central DEXA
By Application
• Bone Densitometry
• Pediatric Assessments
• Others
By End-User
• Hospitals
• Diagnostic Centers
• Research Institutes
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Hologic, Inc, GE Healthcare, Osteosys Co., Ltd, Swissray International, Inc, Medilink, Xuzhou Pinyuan Electronic Technology, Eurotec Medical Systems, Medical Econet, Medikors, Demetech AB and among others.
Key Developments
• In October, 2022, in collaboration with Quality HealthCare Medical Services (QHMS), HKT's one-stop telemedicine platform DrGo launched "Care for Osteoporosis," a focused osteoporosis awareness campaign that will go public on World Osteoporosis Day. The campaign's goals are to lower fracture risks associated with low bone density and raise public awareness of bone health. To that end, 100 high-risk individuals will receive sponsorships from QHMS to undertake bone density examinations.
• In July 2022, DEXA scans are a quick and simple bone density test that Parvathy Hospital started the uses to identify osteoporosis and other diseases related to bone density. DEXA is most frequently used to assess bone mineral density in the hip and lumbar (lower) spine; however, it can assess bone mineral density in any bone. Assessing for spinal fractures is another purpose for the examination.
Why Purchase the Report?
• To visualize the global dual-energy x-ray absorptiometry market segmentation based on type, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of dual-energy x-ray absorptiometry market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global Dual-energy X-ray Absorptiometry market report would provide approximately 69 tables, 58 figures and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing the prevalence of osteoporosis
4.1.1.2. The technological advancements of the products
4.2. Restraints
4.2.1.1. High cost associated with DEXA devices
4.2.2. Opportunity
4.2.3. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Peripheral DEXA *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Central DEXA
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Bone Densitometry *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Pediatric Assessments
8.4. Others
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Diagnostic Centers
9.4. Research Institutes
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Hologic, Inc *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. GE Healthcare
12.3. Osteosys Co., Ltd
12.4. Swissray International, Inc
12.5. Medilink
12.6. Xuzhou Pinyuan Electronic Technology
12.7. Eurotec Medical Systems
12.8. Medical Econet
12.9. Medikors
12.10. Demetech AB
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us